×

Kraig Biocraft Laboratories to Establish Additional Production Operations for Spider Silk

ANN ARBOR, Mich., May 16, 2016 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company is planning on establishing more than one additional production location, including domestic options, that would operate in parallel to its announced plans for operations in Vietnam.

The additional production sites will allow Kraig Labs to more rapidly fulfill outstanding material requests, from our collaboration partners and prospective clients, for recombinant spider silk fibers.

“Although securing a healthy supply of suitable mulberry leaves, to establish our domestic production, is a challenge, I believe that this initiative will yield many benefits, including enhancement of our R&D efforts. Additionally, some of our end users may require that certain fibers are produced domestically, so this move places us ahead of that curve,” said COO Jon Rice.

For further information from the Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter/

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company, is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC (720) 288-8495 ir@KraigLabs.com

Source:Kraig Biocraft Laboratories, Inc.